Author

Matteo Bianchi

Observed names: Bianchi, Matteo, M. Bianchi

Institution: Molecular Partners (Switzerland)

Observed institutions: Scripps Research Institute, International AIDS Vaccine Initiative, University of Zurich, Molecular Partners (Switzerland), University Children's Hospital Zurich, University of Lausanne

ORCID: 0000-0003-0517-8599

Observed ORCID: 0000-0003-0517-8599

OpenAlex ID: A5053298024

Restoration of NET formation by gene therapy in CGD controls aspergillosis

2009 · Matteo Bianchi, Abdul Hakkim, et al. · Blood · 612

PDF

Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent

2011 · Matteo Bianchi, Maria J. Niemiec, et al. · Journal of Allergy and Clinical Immunology · 254

Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization

2018 · Matteo Bianchi, Hannah L. Turner, et al. · Immunity · 200

PDF

Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers

2018 · Matthias G. Pauthner, Joseph P. Nkolola, et al. · Immunity · 160

PDF

Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines

2020 · Bartek Nogal, Matteo Bianchi, et al. · Cell Reports · 86

PDF

Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses

2018 · Michael A. Maurer, Larissa Meyer, et al. · Cell Reports · 85

PDF

Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer

2008 · Hakim Echchannaoui, Matteo Bianchi, et al. · Infection and Immunity · 47

Heterosubtypic Antibodies to Influenza A Virus Have Limited Activity against Cell-Bound Virus but Are Not Impaired by Strain-Specific Serum Antibodies

2015 · Arkadiusz Wyrzucki, Matteo Bianchi, et al. · Journal of Virology · 28

Human miR223 Promoter as a Novel Myelo-Specific Promoter for Chronic Granulomatous Disease Gene Therapy

2013 · Christian Brendel, Walther Hänseler, et al. · Human Gene Therapy Methods · 26

The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells

2024 · Matteo Bianchi, Christian Reichen, et al. · Cancer Immunology Research · 17

PDF

Prevalence and Predictors for Homo- and Heterosubtypic Antibodies Against Influenza A Virus

2014 · Ines Kohler, Alexandra U. Scherrer, et al. · Clinical Infectious Diseases · 10

PDF

Oxygen consumption in offspring tawny owls Strix aluco is associated with colour morph of foster mother

2005 · Alexandre Roulin, Pierre Bize, et al. · Journal für Ornithologie · 10

The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals

2015 · Ines Kohler, Roger Kouyos, et al. · AIDS · 9

PDF

Response: Protecting against Aspergillus infection in CGD

2009 · Abdul Hakkim, Robert Hurwitz, et al. · Blood · 2

PDF

Abstract 3119: Next-generation multi-specific and conditionally activated CD3 Switch-DARPins with CD2 co-stimulation to tackle the current limitations of T cell engagers in solid tumors

2025 · Matteo Bianchi, Marco Franchini, et al. · Cancer Research · 1

Protecting against Aspergillus infection in CGD Response

2009 · Hakkim, Abdul, Hurwitz, Robert, et al. · Max Planck Institute for Plasma Physics · 1

1072 MP0632, a logic-gated conditional Switch-DARPin T cell engager with CD2 co-stimulation enabling selective activity against solid tumors co-expressing MSLN and EpCAM

2026 · Stephan Wullschleger, Matteo Bianchi, et al. · Journal for ImmunoTherapy of Cancer

PDF

Abstract 1624: Logic-gated switch-DARPin T cell engager with CD2 co-stimulation for improved safety and efficacy in MSLN and EpCAM co-expressing ovarian cancer

2026 · Matteo Bianchi, Sarah Jetzer, et al. · Cancer Research

829 A next-generation conditional Switch-DARPin T cell engager with CD2 co-stimulation enabling selective activity against solid tumors which co-express mesothelin (MSLN) and EpCAM

2025 · Matteo Bianchi, Joanna Robinson, et al. · Journal for ImmunoTherapy of Cancer

PDF

Data from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells